Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lijiang Jishi Pharmaceutical Co., Ltd. is a pharmaceutical company based in Lijiang, Yunnan Province, China, specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern pharmaceutical products. The company is well-known for its focus on natural products derived from the unique flora of the Yunnan-Guizhou Plateau. Its product portfolio includes treatments for cardiovascular conditions, respiratory ailments, and general inflammatory diseases. Key products include Shengmai Injection and various herbal tablets and granules. Lijiang Jishi operates as a high-tech enterprise with GMP-certified manufacturing facilities, serving both domestic and international markets with a focus on integrating traditional wisdom with modern medical standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lijiang Ji.